Atenolol versus losartan in children and young adults with Marfan's syndrome Academic Article uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Aorta
  • Aortic Aneurysm
  • Atenolol
  • Losartan
  • Marfan Syndrome

abstract

  • Among children and young adults with Marfan's syndrome who were randomly assigned to losartan or atenolol, we found no significant difference in the rate of aortic-root dilatation between the two treatment groups over a 3-year period. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00429364.).

authors

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4386623

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1404731

PubMed ID

  • 25405392

Additional Document Info

start page

  • 2061

end page

  • 71

volume

  • 371

number

  • 22